Cellaria

5 articles about Cellaria

• Cellaria Inc Launches New Cell Lines to Support the Development of Personalized Therapies for Lung Cancer

  5/25/2021

  Cellaria Inc (Wakefield, MA, USA), a scientific innovator with breakthrough tools for cancer research, now offers five stable, fully authenticated lung cancer cell models to support the development of more effective and targeted drug therapies.

• Vyant Bio, Inc., Ordaōs Bio, and Cellaria, Inc. Announce Collaboration to Design and Qualify Biomarker-Specific Small Protein Therapeutics

  4/22/2021

  New collaboration mitigates risk in drug d iscovery process with artificial intelligence and in vitro “avatar” clinical trials

• Cellaria Inc. Partners With Researchers at Northeastern University to Advance New Photomedicine Therapies for Key Cancers

  12/1/2020

  Cellaria Inc (Wakefield, MA, USA) and the Spring Lab, Northeastern University, announce the successful receipt of a National Institutes of Health (NIH) R01 grant to extend and advance the application of innovative new photomedicine-based therapies for hard-to-treat cancers. The grant highlights the close working relationshi

• Cellaria, Inc. Introduces A New Generation Of Cell Line Models For Pancreatic Cancer Paving The Way For Better Treatment

  10/15/2020

  Cellaria, Inc. (Wakefield, MA, USA), a scientific innovator with breakthrough tools for cancer research, has introduced three next generation Pancreatic Cancer cell lines, substantially boosting the value of in vitro methods in the development of more effective therapies. Difficult to detect

• Cellaria And Biological Industries USA Partner On Stem Cell Media And Research

  5/4/2017